Clinical Trials Browser

Completed × glucopyranosyl lipid-A × Dermatologic × Clear all

NCT02320305 2020-01-14

MART-1 Antigen With or Without TLR4 Agonist GLA-SE in Treating Patients With Stage II-IV Melanoma That Has Been Removed by Surgery

Phase EARLY_PHASE1 Completed

Melanoma

NCT02035657 2018-06-13

A Proof-of-Concept Trial of GLA-SE in Patients With Merkel Cell Carcinoma

Phase 1 Completed

Carcinoma, Merkel Cell